Endocrine Abstracts

Background: Pegylated interferon-alpha (IFN-α) is licensed as an antiviral, immunomodulatory and anti-proliferative therapy, but may induce autoimmune conditions including Type 1 diabetes Mellitus/latent Autoimmune Diabetes of Adults (LADA). Case Report: A 50-year-old male presented with a 3-week history of polyuria, polydipsia and weight loss. Following review by his General Practitioner he was found to have an elevated serum glucose (55.4 mmol/l)....